Ruinuo Pharmaceutical's 1,200 t/a L-alanine project accepted for environmental protection

Summary: On 4 Jan., 2022, the environmental protection acceptance of the second phase project of nucleotide series products, vitamin B1 intermediate, vitamin B5 intermediate products (1,200 t/a L-alanine) and acetonitrile of Ruinuo Pharmaceutical was...

Amino Acids China E-News 202201

www.cnchemicals.com